WuXi AppTec and WuXi Biologics respond to rumors of divestment: evaluating operational options, conducting regular business reviews

robot
Abstract generation in progress

On October 4th, Jin10 Data reported that Pharmaron and Pharmaron Biotech are working on the sale of some of their businesses, among which Pharmaron will sell WuXi Advanced Therapies. Discussions have been ongoing for months and contract manufacturers have been approached to acquire all or part of the assets. On October 4th, Pharmaron stated to reporters that we are evaluating options to continue operating WuXi Advanced Therapies (high-end treatment business) to meet our priorities: our employees and patients in need of basic, time-critical, life-saving treatments.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)